Search Results - mohamed+al-shabrawey

1 Results

Sort By:

The use of EETs blocker or antagonists to enhance the efficacy of AT1 blocker to treat diabetic retinopathy.

The use of EETs Blocker or Antagonists to Enhance the Efficacy of AT1 blocker to Treat Diabetic Retinopathy Application: Diabetic Retinopathy (DR) Advantages/Benefits: • This technology in combination with AT1 receptor blockade prevents and reduces DR • This technology can address the 33% of the U.S. population predicted...

Published: 11/23/2021 | Inventor(s): Mong-Heng Wang, Mohamed Al-Shabrawey

Keywords(s):

Category(s): Therapeutics